Boehringer Ingelheim adds filling line to Shanghai biopharma facility

Boehringer Ingelheim has added a new filling line to its OASIS facility in Shanghai, China, expanding its contract drug manufacturing capabilities for biopharmaceuticals. The expansion includes an isolator-based fill & finish line for aseptic filling of liquids in vials.

“I believe that our customers will benefit from this investment by receiving high quality drug substance and drug product from one source as a convenient pathway to deliver biopharmaceuticals to our customers and, in the end, to patients.”pharmaceutical-technology.com

• 1 source
• pharmaceutical-technology.comBoehringer expands drug manufacturing capabilities in ChinaDivya TirumalarajuJul 5, 2018

Summarized from public sources; check the original articles before acting on it.